The Retroviruses conference, considered by many to be the single most important scientific conference on AIDS, last took place January 30 - February 2 in San Francisco. Now a 32-page report offers short, readable summaries of many of the important treatment topics presented.

Major sections include:

• Structured and Unstructured Treatment Interruptions;
• Experimental Drugs in Development;
• Once-Daily Dosing;
• Selected Anti-HIV Study Results;
• Changes in Natural History of HIV Disease;
• Fat Redistribution, Metabolic Complications, and "Switch" Studies;
• Experimental Vaccines and Immunology;
• Drug Interactions with Anti-HIV Drugs & Other Adverse Effects;
• HIV Drug Resistance Testing;
• HIV-Related Opportunistic Infections and Cancers;
• Women, Pregnancy & Prevention/Transmission to Newborns;
• Adherence;
• Co-Infection with Hepatitis B Virus;
• Co-Infection with Hepatitis C Virus;
• Post-Exposure Prophylaxis (Prevention); and
• HIV Transmission

This report was written by Harvey S. Bartnof, M.D., Medical Editor of HIV and Hepatitis.com. It was supported by an unrestricted educational grant from DuPont Pharmaceuticals. A more comprehensive version is available at: http://www.hivandhepatitis.com/conferences/retro7.html

For a free copy of the printed report, send your mailing address to: HIV and Hepatitis.com, P.O. Box 14288, San Francisco, CA 94114. (You can also request a printed copy by email to: ronbaker@dnai.com .)

ISSN # 1052-4207

Copyright 2000 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.

Back to the AIDS Treatment News May 5, 2000 contents page.